APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pigmented Villonodular Synovitis Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pigmented Villonodular Synovitis Drug Industry Growth and Trends Forecast to 2032

19 December 202576 pages

Choose your research edition.

Industry ResearchPigmented Villonodular Synovitis Drug Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Pigmented Villonodular Synovitis Drug Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Pigmented Villonodular Synovitis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pigmented Villonodular Synovitis Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pigmented Villonodular Synovitis Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Pigmented Villonodular Synovitis Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pigmented Villonodular Synovitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pigmented Villonodular Synovitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pigmented Villonodular Synovitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pigmented Villonodular Synovitis Drug include Novartis AG, Bristol-Myers Squibb Co, Plexxikon Inc and F. Hoffmann-La Roche Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pigmented Villonodular Synovitis Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pigmented Villonodular Synovitis Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pigmented Villonodular Synovitis Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pigmented Villonodular Synovitis Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pigmented Villonodular Synovitis Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pigmented Villonodular Synovitis Drug Market by Company

Novartis AG

Bristol-Myers Squibb Co

Plexxikon Inc

F. Hoffmann-La Roche Ltd

Pigmented Villonodular Synovitis Drug Segment by Type

Nilotinib

Cabiralizumab

Emactuzumab

Mcs-110

Others

Pigmented Villonodular Synovitis Drug Segment by Application

Hospital

Clinic

Others

Pigmented Villonodular Synovitis Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pigmented Villonodular Synovitis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pigmented Villonodular Synovitis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pigmented Villonodular Synovitis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pigmented Villonodular Synovitis Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pigmented Villonodular Synovitis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Nilotinib Table 2. Major Company of Cabiralizumab Table 3. Major Company of Emactuzumab Table 4. Major Company of Mcs-110 Table 5. Major Company of Others Table 6. Global Pigmented Villonodular Synovitis Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pigmented Villonodular Synovitis Drug Sales by Type (2021-2026) & (K Units) Table 8. Global Pigmented Villonodular Synovitis Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Pigmented Villonodular Synovitis Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Pigmented Villonodular Synovitis Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Pigmented Villonodular Synovitis Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global Pigmented Villonodular Synovitis Drug Sales by Type (2027-2032) & (K Units) Table 13. Global Pigmented Villonodular Synovitis Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Pigmented Villonodular Synovitis Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Pigmented Villonodular Synovitis Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Pigmented Villonodular Synovitis Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America Pigmented Villonodular Synovitis Drug Sales by Type (2021-2026) & (K Units) Table 18. North America Pigmented Villonodular Synovitis Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Pigmented Villonodular Synovitis Drug Sales by Type (2021-2026) & (K Units) Table 20. Europe Pigmented Villonodular Synovitis Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Pigmented Villonodular Synovitis Drug Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Pigmented Villonodular Synovitis Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Pigmented Villonodular Synovitis Drug Sales by Type (2021-2026) & (K Units) Table 24. Latin America Pigmented Villonodular Synovitis Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Pigmented Villonodular Synovitis Drug Industry Trends Table 28. Pigmented Villonodular Synovitis Drug Industry Drivers Table 29. Pigmented Villonodular Synovitis Drug Industry Opportunities and Challenges Table 30. Pigmented Villonodular Synovitis Drug Industry Restraints Table 31. Global Pigmented Villonodular Synovitis Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Pigmented Villonodular Synovitis Drug Revenue Market Share by Company (2021-2026) Table 33. Global Pigmented Villonodular Synovitis Drug Sales by Company (2021-2026) & (K Units) Table 34. Global Pigmented Villonodular Synovitis Drug Sales Share by Company (2021-2026) Table 35. Global Pigmented Villonodular Synovitis Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Pigmented Villonodular Synovitis Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Pigmented Villonodular Synovitis Drug Major Company Production Sites and Headquarters Table 38. Global Pigmented Villonodular Synovitis Drug Company, Product Type & Application Table 39. Global Pigmented Villonodular Synovitis Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Pigmented Villonodular Synovitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Pigmented Villonodular Synovitis Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Pigmented Villonodular Synovitis Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Pigmented Villonodular Synovitis Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Pigmented Villonodular Synovitis Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Pigmented Villonodular Synovitis Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Pigmented Villonodular Synovitis Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Pigmented Villonodular Synovitis Drug Sales by Region (2027-2032) & (K Units) Table 49. Global Pigmented Villonodular Synovitis Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Pigmented Villonodular Synovitis Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Pigmented Villonodular Synovitis Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Pigmented Villonodular Synovitis Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Pigmented Villonodular Synovitis Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Pigmented Villonodular Synovitis Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Pigmented Villonodular Synovitis Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Pigmented Villonodular Synovitis Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Pigmented Villonodular Synovitis Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Pigmented Villonodular Synovitis Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Pigmented Villonodular Synovitis Drug Sales by Application (2027-2032) & (K Units) Table 60. Global Pigmented Villonodular Synovitis Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Pigmented Villonodular Synovitis Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Pigmented Villonodular Synovitis Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Pigmented Villonodular Synovitis Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America Pigmented Villonodular Synovitis Drug Sales by Application (2021-2026) & (K Units) Table 65. North America Pigmented Villonodular Synovitis Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Pigmented Villonodular Synovitis Drug Sales by Application (2021-2026) & (K Units) Table 67. Europe Pigmented Villonodular Synovitis Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Pigmented Villonodular Synovitis Drug Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Pigmented Villonodular Synovitis Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Pigmented Villonodular Synovitis Drug Sales by Application (2021-2026) & (K Units) Table 71. Latin America Pigmented Villonodular Synovitis Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Novartis AG Company Information Table 75. Novartis AG Business Overview Table 76. Novartis AG Pigmented Villonodular Synovitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Novartis AG Pigmented Villonodular Synovitis Drug Product Portfolio Table 78. Novartis AG Recent Development Table 79. Bristol-Myers Squibb Co Company Information Table 80. Bristol-Myers Squibb Co Business Overview Table 81. Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Product Portfolio Table 83. Bristol-Myers Squibb Co Recent Development Table 84. Plexxikon Inc Company Information Table 85. Plexxikon Inc Business Overview Table 86. Plexxikon Inc Pigmented Villonodular Synovitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Plexxikon Inc Pigmented Villonodular Synovitis Drug Product Portfolio Table 88. Plexxikon Inc Recent Development Table 89. F. Hoffmann-La Roche Ltd Company Information Table 90. F. Hoffmann-La Roche Ltd Business Overview Table 91. F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Product Portfolio Table 93. F. Hoffmann-La Roche Ltd Recent Development Table 94. North America Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 95. North America Pigmented Villonodular Synovitis Drug Sales by Country (2021-2026) & (K Units) Table 96. North America Pigmented Villonodular Synovitis Drug Sales Market Share by Country (2021-2026) Table 97. North America Pigmented Villonodular Synovitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 98. North America Pigmented Villonodular Synovitis Drug Sales Market Share Forecast by Country (2027-2032) Table 99. North America Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 100. North America Pigmented Villonodular Synovitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 101. North America Pigmented Villonodular Synovitis Drug Market Share by Country (2021-2026) Table 102. North America Pigmented Villonodular Synovitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 103. North America Pigmented Villonodular Synovitis Drug Market Share Forecast by Country (2027-2032) Table 104. Europe Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 105. Europe Pigmented Villonodular Synovitis Drug Sales by Country (2021-2026) & (K Units) Table 106. Europe Pigmented Villonodular Synovitis Drug Sales Market Share by Country (2021-2026) Table 107. Europe Pigmented Villonodular Synovitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 108. Europe Pigmented Villonodular Synovitis Drug Sales Market Share Forecast by Country (2027-2032) Table 109. Europe Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. Europe Pigmented Villonodular Synovitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 111. Europe Pigmented Villonodular Synovitis Drug Market Share by Country (2021-2026) Table 112. Europe Pigmented Villonodular Synovitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. Europe Pigmented Villonodular Synovitis Drug Market Share Forecast by Country (2027-2032) Table 114. Asia-Pacific Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 115. Asia-Pacific Pigmented Villonodular Synovitis Drug Sales by Country (2021-2026) & (K Units) Table 116. Asia-Pacific Pigmented Villonodular Synovitis Drug Sales Market Share by Country (2021-2026) Table 117. Asia-Pacific Pigmented Villonodular Synovitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 118. Asia-Pacific Pigmented Villonodular Synovitis Drug Sales Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Pigmented Villonodular Synovitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 121. Asia-Pacific Pigmented Villonodular Synovitis Drug Market Share by Country (2021-2026) Table 122. Asia-Pacific Pigmented Villonodular Synovitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Asia-Pacific Pigmented Villonodular Synovitis Drug Market Share Forecast by Country (2027-2032) Table 124. Latin America Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. Latin America Pigmented Villonodular Synovitis Drug Sales by Country (2021-2026) & (K Units) Table 126. Latin America Pigmented Villonodular Synovitis Drug Sales Market Share by Country (2021-2026) Table 127. Latin America Pigmented Villonodular Synovitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 128. Latin America Pigmented Villonodular Synovitis Drug Sales Market Share Forecast by Country (2027-2032) Table 129. Latin America Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Latin America Pigmented Villonodular Synovitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 131. Latin America Pigmented Villonodular Synovitis Drug Market Share by Country (2021-2026) Table 132. Latin America Pigmented Villonodular Synovitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Latin America Pigmented Villonodular Synovitis Drug Market Share Forecast by Country (2027-2032) Table 134. Middle East and Africa Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales by Country (2021-2026) & (K Units) Table 136. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Market Share by Country (2021-2026) Table 137. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 138. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Pigmented Villonodular Synovitis Drug Market Size by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Pigmented Villonodular Synovitis Drug Market Share by Country (2021-2026) Table 142. Middle East and Africa Pigmented Villonodular Synovitis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Middle East and Africa Pigmented Villonodular Synovitis Drug Market Share Forecast by Country (2027-2032) Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Pigmented Villonodular Synovitis Drug Distributors List Table 147. Pigmented Villonodular Synovitis Drug Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Pigmented Villonodular Synovitis Drug Image Figure 2. Global Pigmented Villonodular Synovitis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pigmented Villonodular Synovitis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Pigmented Villonodular Synovitis Drug Sales (2021-2032) & (K Units) Figure 5. Nilotinib Image Figure 6. Global Nilotinib Sales YoY Growth (2021-2032) & (K Units) Figure 7. Cabiralizumab Image Figure 8. Global Cabiralizumab Sales YoY Growth (2021-2032) & (K Units) Figure 9. Emactuzumab Image Figure 10. Global Emactuzumab Sales YoY Growth (2021-2032) & (K Units) Figure 11. Mcs-110 Image Figure 12. Global Mcs-110 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Pigmented Villonodular Synovitis Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Pigmented Villonodular Synovitis Drug Market Share by Type 2025 VS 2032 Figure 17. North America Pigmented Villonodular Synovitis Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Pigmented Villonodular Synovitis Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Pigmented Villonodular Synovitis Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Pigmented Villonodular Synovitis Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Pigmented Villonodular Synovitis Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Pigmented Villonodular Synovitis Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Pigmented Villonodular Synovitis Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Pigmented Villonodular Synovitis Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Pigmented Villonodular Synovitis Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Pigmented Villonodular Synovitis Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Pigmented Villonodular Synovitis Drug Market Share by Application 2025 VS 2032 Figure 37. North America Pigmented Villonodular Synovitis Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Pigmented Villonodular Synovitis Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Pigmented Villonodular Synovitis Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Pigmented Villonodular Synovitis Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Pigmented Villonodular Synovitis Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Pigmented Villonodular Synovitis Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Pigmented Villonodular Synovitis Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Pigmented Villonodular Synovitis Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Pigmented Villonodular Synovitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Pigmented Villonodular Synovitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Pigmented Villonodular Synovitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Pigmented Villonodular Synovitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Pigmented Villonodular Synovitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Pigmented Villonodular Synovitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Pigmented Villonodular Synovitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Pigmented Villonodular Synovitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Pigmented Villonodular Synovitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Pigmented Villonodular Synovitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Pigmented Villonodular Synovitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Pigmented Villonodular Synovitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Pigmented Villonodular Synovitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Pigmented Villonodular Synovitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Pigmented Villonodular Synovitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Pigmented Villonodular Synovitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Pigmented Villonodular Synovitis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Pigmented Villonodular Synovitis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Pigmented Villonodular Synovitis Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Pigmented Villonodular Synovitis Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Nilotinib
  • Cabiralizumab
  • Emactuzumab
  • Mcs-110
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novartis AG
  • Bristol-Myers Squibb Co
  • Plexxikon Inc
  • F. Hoffmann-La Roche Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pigmented Villonodular Synovitis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pigmented Villonodular Synovitis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pigmented Villonodular Synovitis Drug Market by Type
  6. 1.3.1 Nilotinib
  7. 1.3.2 Cabiralizumab
  8. 1.3.3 Emactuzumab
  9. 1.3.4 Mcs-110
  10. 1.3.5 Others
  11. 1.4 Global Pigmented Villonodular Synovitis Drug Market Size by Type
  12. 1.4.1 Global Pigmented Villonodular Synovitis Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Pigmented Villonodular Synovitis Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Pigmented Villonodular Synovitis Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Pigmented Villonodular Synovitis Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Pigmented Villonodular Synovitis Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Pigmented Villonodular Synovitis Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Pigmented Villonodular Synovitis Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pigmented Villonodular Synovitis Drug Industry Trends
  2. 2.2 Pigmented Villonodular Synovitis Drug Industry Drivers
  3. 2.3 Pigmented Villonodular Synovitis Drug Industry Opportunities and Challenges
  4. 2.4 Pigmented Villonodular Synovitis Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pigmented Villonodular Synovitis Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Pigmented Villonodular Synovitis Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Pigmented Villonodular Synovitis Drug Price (2021-2026)
  4. 3.4 Global Pigmented Villonodular Synovitis Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pigmented Villonodular Synovitis Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Pigmented Villonodular Synovitis Drug Company, Product Type & Application
  7. 3.7 Global Pigmented Villonodular Synovitis Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pigmented Villonodular Synovitis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pigmented Villonodular Synovitis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pigmented Villonodular Synovitis Drug Tier 1, Tier 2, and Tier 3
4 Pigmented Villonodular Synovitis Drug Regional Status and Outlook
  1. 4.1 Global Pigmented Villonodular Synovitis Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pigmented Villonodular Synovitis Drug Historic Market Size by Region
  3. 4.2.1 Global Pigmented Villonodular Synovitis Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pigmented Villonodular Synovitis Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pigmented Villonodular Synovitis Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pigmented Villonodular Synovitis Drug Forecasted Market Size by Region
  7. 4.3.1 Global Pigmented Villonodular Synovitis Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pigmented Villonodular Synovitis Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pigmented Villonodular Synovitis Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pigmented Villonodular Synovitis Drug by Application
  1. 5.1 Pigmented Villonodular Synovitis Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Pigmented Villonodular Synovitis Drug Market Size by Application
  6. 5.2.1 Global Pigmented Villonodular Synovitis Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pigmented Villonodular Synovitis Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pigmented Villonodular Synovitis Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pigmented Villonodular Synovitis Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pigmented Villonodular Synovitis Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pigmented Villonodular Synovitis Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pigmented Villonodular Synovitis Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Pigmented Villonodular Synovitis Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Pigmented Villonodular Synovitis Drug Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Bristol-Myers Squibb Co
  8. 6.2.1 Bristol-Myers Squibb Co Company Information
  9. 6.2.2 Bristol-Myers Squibb Co Business Overview
  10. 6.2.3 Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Product Portfolio
  12. 6.2.5 Bristol-Myers Squibb Co Recent Developments
  13. 6.3 Plexxikon Inc
  14. 6.3.1 Plexxikon Inc Company Information
  15. 6.3.2 Plexxikon Inc Business Overview
  16. 6.3.3 Plexxikon Inc Pigmented Villonodular Synovitis Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Plexxikon Inc Pigmented Villonodular Synovitis Drug Product Portfolio
  18. 6.3.5 Plexxikon Inc Recent Developments
  19. 6.4 F. Hoffmann-La Roche Ltd
  20. 6.4.1 F. Hoffmann-La Roche Ltd Company Information
  21. 6.4.2 F. Hoffmann-La Roche Ltd Business Overview
  22. 6.4.3 F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Product Portfolio
  24. 6.4.5 F. Hoffmann-La Roche Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Pigmented Villonodular Synovitis Drug Sales by Country
  2. 7.1.1 North America Pigmented Villonodular Synovitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pigmented Villonodular Synovitis Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Pigmented Villonodular Synovitis Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pigmented Villonodular Synovitis Drug Market Size by Country
  6. 7.2.1 North America Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pigmented Villonodular Synovitis Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Pigmented Villonodular Synovitis Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pigmented Villonodular Synovitis Drug Sales by Country
  2. 8.1.1 Europe Pigmented Villonodular Synovitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pigmented Villonodular Synovitis Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Pigmented Villonodular Synovitis Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pigmented Villonodular Synovitis Drug Market Size by Country
  6. 8.2.1 Europe Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pigmented Villonodular Synovitis Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pigmented Villonodular Synovitis Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pigmented Villonodular Synovitis Drug Sales by Country
  2. 9.1.1 Asia-Pacific Pigmented Villonodular Synovitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pigmented Villonodular Synovitis Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pigmented Villonodular Synovitis Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pigmented Villonodular Synovitis Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pigmented Villonodular Synovitis Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pigmented Villonodular Synovitis Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pigmented Villonodular Synovitis Drug Sales by Country
  2. 10.1.1 South America Pigmented Villonodular Synovitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pigmented Villonodular Synovitis Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Pigmented Villonodular Synovitis Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pigmented Villonodular Synovitis Drug Market Size by Country
  6. 10.2.1 South America Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pigmented Villonodular Synovitis Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Pigmented Villonodular Synovitis Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pigmented Villonodular Synovitis Drug Sales by Country
  2. 11.1.1 Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pigmented Villonodular Synovitis Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pigmented Villonodular Synovitis Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pigmented Villonodular Synovitis Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pigmented Villonodular Synovitis Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pigmented Villonodular Synovitis Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pigmented Villonodular Synovitis Drug Value Chain Analysis
  2. 12.1.1 Pigmented Villonodular Synovitis Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pigmented Villonodular Synovitis Drug Production Mode & Process
  7. 12.2 Pigmented Villonodular Synovitis Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pigmented Villonodular Synovitis Drug Distributors
  10. 12.2.3 Pigmented Villonodular Synovitis Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst